Last edition
News about Global Pharma
Novo Nordisk's Wegovy Approved for Treatment of MASH in Adults with Liver Fibrosis
The US FDA has approved an additional indication for Wegovy (semaglutide 2.4 mg) for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis, according to Novo Nordisk.
Global Pharma | 16/08/2025 | By Dineshwori | 366
US-based biopharmaceutical company Precigen has received approval from the Food and Drug Administration (FDA) for its immunotherapy PAPZIMEOS (zopapogene imadenovec-drba) for the treatment of adults with recurrent respiratory papillomatosis (RRP).
Global Pharma | 16/08/2025 | By Dineshwori | 209
Vcare, Huadong Medicine Join Forces to Commercialise JAK1 Inhibitor VC005 Tablets in China
Jiangsu Vcare Pharmatech has entered an exclusive strategic partnership with Huadong Medicine to commercialize its innovative JAK1 inhibitor VC005 tablets for autoimmune diseases in China.
Global Pharma | 16/08/2025 | By Mrinmoy Dey | 438
Shilpa Medicare Secures CDSCO Approval for NorUDCA Tablets in NAFLD Treatment
Shilpa Medicare Ltd has received approval from India's Central Drugs Standard Control Organization (CDSCO) for Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg for the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD).
Global Pharma | 16/08/2025 | By Dineshwori | 634
Superluminal and Eli Lilly Partner on Next-Gen Cardiometabolic and Obesity Treatments
Superluminal Medicines has announced a collaboration with Eli Lilly and Company to advance small molecule therapeutics for cardiometabolic diseases and obesity.
Global Pharma | 16/08/2025 | By Dineshwori | 239
Trump Directs HHS to Fill Strategic API Reserve to Bolster Pharma Supply Chain
US President Donald Trump has signed an executive order to strengthen the American pharmaceutical supply chain resilience by filling the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR).
Global Pharma | 14/08/2025 | By Dineshwori | 330
BioDlink Launches Bevacizumab Biosimilar in Colombia and Pakistan
BioDlink’s bevacizumab injection secures marketing authorization in Colombia and Pakistan following its recent approval in Nigeria.<br />
Global Pharma | 14/08/2025 | By Dineshwori | 264
Avendus Invests INR 300 Cr in Aragen Life Sciences
Avendus Future Leaders Fund (FLF), the flagship private strategies fund of the Avendus Group, has led an INR 300 crore investment in Aragen Life Sciences from its third fund, along with SBI Life Insurance.
Global Pharma | 14/08/2025 | By Dineshwori | 263
Sartorius Stedim Biotech Partners with Nanotein Technologies to Advance Cell Therapy Manufacturing
Sartorius Stedim Biotech partners with Nanotein Technologies, investing up to USD 3 million to commercialise and distribute NanoSpark immune cell activation solutions for cell therapy applications.
Global Pharma | 14/08/2025 | By Mrinmoy Dey | 143
Apriori Bio Partners with Francis Crick Institute to Advance Variant-Resilient Vaccine Research
Apriori Bio has partnered with the Francis Crick Institute to leverage AI-driven insights and the Crick’s Legacy Study for developing variant-resilient vaccines against current and emerging viral threats.
Global Pharma | 14/08/2025 | By Mrinmoy Dey | 251
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy